pubmed-article:16713113 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:16713113 | lifeskim:mentions | umls-concept:C0021289 | lld:lifeskim |
pubmed-article:16713113 | lifeskim:mentions | umls-concept:C0035820 | lld:lifeskim |
pubmed-article:16713113 | lifeskim:mentions | umls-concept:C0034693 | lld:lifeskim |
pubmed-article:16713113 | lifeskim:mentions | umls-concept:C0021760 | lld:lifeskim |
pubmed-article:16713113 | lifeskim:mentions | umls-concept:C0004927 | lld:lifeskim |
pubmed-article:16713113 | lifeskim:mentions | umls-concept:C0270611 | lld:lifeskim |
pubmed-article:16713113 | lifeskim:mentions | umls-concept:C0277785 | lld:lifeskim |
pubmed-article:16713113 | lifeskim:mentions | umls-concept:C1555903 | lld:lifeskim |
pubmed-article:16713113 | pubmed:issue | 2 | lld:pubmed |
pubmed-article:16713113 | pubmed:dateCreated | 2006-7-24 | lld:pubmed |
pubmed-article:16713113 | pubmed:abstractText | There are increasing data in support of the hypothesis that inflammatory cytokines are involved in neonatal white matter damage. Despite extensive study of the proinflammatory cytokines tumor necrosis factor-alpha and interleukin-1beta, the role of interleukin-6 in the development of white matter damage is largely unknown. In the present study, the role(s) of interleukin-6 in mediating lipopolysaccharide-induced brain injury and behavioral changes was investigated by the intracerebral injection of lipopolysaccharide with interleukin-6 neutralizing antibody in the 5-day-old rat brain. Brain injury was examined in brain sections at postnatal day 8 and postnatal day 21. Behavioral tests including righting reflex, wire hanging maneuver, cliff avoidance, locomotor activity, gait analysis, responses in the elevated plus-maze and passive avoidance were performed from postnatal day 3 to postnatal day 21. Changes in astroglia, microglia and oligodendrocytes were studied using immunohistochemistry in the postnatal day 21 rat brain. Our results show that interleukin-6 antibody attenuated lipopolysaccharide-induced brain lateral ventricle dilation and improved neurobehavioral performance. Interleukin-6 antibody also suppressed lipopolysaccharide-induced astrogliosis and microglial activation, and increased the number of oligodendrocytes in white matter. However, no changes of tumor necrosis factor-alpha and interleukin-1beta were detected. In contrast, no histopathological changes and glial activation were observed in rats injected with only interleukin-6. The present study indicates that the contribution to brain injury by interleukin-6 depends on its interaction with other lipopolysaccharide-induced agents and not on interleukin-6 alone. | lld:pubmed |
pubmed-article:16713113 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:16713113 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:16713113 | pubmed:language | eng | lld:pubmed |
pubmed-article:16713113 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:16713113 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:16713113 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:16713113 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:16713113 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:16713113 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:16713113 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:16713113 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:16713113 | pubmed:month | Aug | lld:pubmed |
pubmed-article:16713113 | pubmed:issn | 0306-4522 | lld:pubmed |
pubmed-article:16713113 | pubmed:author | pubmed-author:RhodesP GPG | lld:pubmed |
pubmed-article:16713113 | pubmed:author | pubmed-author:CanAA | lld:pubmed |
pubmed-article:16713113 | pubmed:author | pubmed-author:BOAP APA | lld:pubmed |
pubmed-article:16713113 | pubmed:author | pubmed-author:PangYY | lld:pubmed |
pubmed-article:16713113 | pubmed:author | pubmed-author:ZhengBB | lld:pubmed |
pubmed-article:16713113 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:16713113 | pubmed:day | 25 | lld:pubmed |
pubmed-article:16713113 | pubmed:volume | 141 | lld:pubmed |
pubmed-article:16713113 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:16713113 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:16713113 | pubmed:pagination | 745-55 | lld:pubmed |
pubmed-article:16713113 | pubmed:dateRevised | 2007-11-14 | lld:pubmed |
pubmed-article:16713113 | pubmed:meshHeading | pubmed-meshheading:16713113... | lld:pubmed |
pubmed-article:16713113 | pubmed:meshHeading | pubmed-meshheading:16713113... | lld:pubmed |
pubmed-article:16713113 | pubmed:meshHeading | pubmed-meshheading:16713113... | lld:pubmed |
pubmed-article:16713113 | pubmed:meshHeading | pubmed-meshheading:16713113... | lld:pubmed |
pubmed-article:16713113 | pubmed:meshHeading | pubmed-meshheading:16713113... | lld:pubmed |
pubmed-article:16713113 | pubmed:meshHeading | pubmed-meshheading:16713113... | lld:pubmed |
pubmed-article:16713113 | pubmed:meshHeading | pubmed-meshheading:16713113... | lld:pubmed |
pubmed-article:16713113 | pubmed:meshHeading | pubmed-meshheading:16713113... | lld:pubmed |
pubmed-article:16713113 | pubmed:meshHeading | pubmed-meshheading:16713113... | lld:pubmed |
pubmed-article:16713113 | pubmed:meshHeading | pubmed-meshheading:16713113... | lld:pubmed |
pubmed-article:16713113 | pubmed:meshHeading | pubmed-meshheading:16713113... | lld:pubmed |
pubmed-article:16713113 | pubmed:meshHeading | pubmed-meshheading:16713113... | lld:pubmed |
pubmed-article:16713113 | pubmed:meshHeading | pubmed-meshheading:16713113... | lld:pubmed |
pubmed-article:16713113 | pubmed:meshHeading | pubmed-meshheading:16713113... | lld:pubmed |
pubmed-article:16713113 | pubmed:meshHeading | pubmed-meshheading:16713113... | lld:pubmed |
pubmed-article:16713113 | pubmed:meshHeading | pubmed-meshheading:16713113... | lld:pubmed |
pubmed-article:16713113 | pubmed:meshHeading | pubmed-meshheading:16713113... | lld:pubmed |
pubmed-article:16713113 | pubmed:meshHeading | pubmed-meshheading:16713113... | lld:pubmed |
pubmed-article:16713113 | pubmed:meshHeading | pubmed-meshheading:16713113... | lld:pubmed |
pubmed-article:16713113 | pubmed:meshHeading | pubmed-meshheading:16713113... | lld:pubmed |
pubmed-article:16713113 | pubmed:meshHeading | pubmed-meshheading:16713113... | lld:pubmed |
pubmed-article:16713113 | pubmed:meshHeading | pubmed-meshheading:16713113... | lld:pubmed |
pubmed-article:16713113 | pubmed:year | 2006 | lld:pubmed |
pubmed-article:16713113 | pubmed:articleTitle | Role of interleukin-6 in lipopolysaccharide-induced brain injury and behavioral dysfunction in neonatal rats. | lld:pubmed |
pubmed-article:16713113 | pubmed:affiliation | Department of Pediatrics, Division of Newborn Medicine, University of Mississippi Medical Center, 2500 North State Street, Jackson, MS 39216, USA. | lld:pubmed |
pubmed-article:16713113 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:16713113 | pubmed:publicationType | Comparative Study | lld:pubmed |
pubmed-article:16713113 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
pubmed-article:16713113 | pubmed:publicationType | Research Support, N.I.H., Extramural | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16713113 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16713113 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16713113 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16713113 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16713113 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16713113 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16713113 | lld:pubmed |